James C. Momtazee, Director at Jazz Pharmaceuticals plc (JAZZ), sold 1,070 shares at $81.86 ($88K) on 2013-08-13, disclosed to the SEC on 2013-08-14.
Open-market sale of $88k JAZZ by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.